TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice

Microbes and Infection

Volumn 7, Issue 15, 2005, Pages 1461-1468

  Wilhelm, Patricia ^a,b   Wiede, Florian ^a,e   Meissner, Anja ^a,f   Donhauser, Norbert ^c   Bogdan, Christian ^c,d   Körner, Heinrich ^a,e  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e JAMES COOK UNIVERSITY   (Australia)

^f UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Fas ligand; Host defense; Protozoan parasite; Tumor necrosis factor

Indexed keywords

FAS LIGAND; INDUCIBLE NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; IMMUNE RESPONSE; IMMUNITY; INFECTION CONTROL; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPH NODE; MOUSE; NONHUMAN; PARASITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; SPLEEN; T LYMPHOCYTE; WILD TYPE;

ANIMALS; ANTIBODIES, PROTOZOAN; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; IMMUNOHISTOCHEMISTRY; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; SKIN; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; TUMOR NECROSIS FACTORS;

ANIMALIA; LEISHMANIA MAJOR; PROTOZOA;

EID: 28944454777     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.05.005     Document Type: Article

References (33)

1. S.L. Reiner, and R.M. Locksley The regulation of immunity to Leishmania major Annu. Rev. Immunol. 13 1995 151 177
2. W. Solbach, and T. Laskay The host response to Leishmania infection Adv. Immunol. 74 2000 275 317
3. D. Sacks, and N. Noben-Trauth The immunology of susceptibility and resistance to Leishmania major in mice Nat. Rev. Immunol. 2 2002 845 858
4. A. Diefenbach, H. Schindler, N. Donhauser, E. Lorenz, T. Laskay, J. MacMicking, M. Röllinghoff, I. Gresser, and C. Bogdan Type 1 interferon (IFN-α/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite Immunity 8 1998 77 87
5. T. Scharton-Kersten, L.C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis J. Immunol. 154 1995 5320 5330
6. S.J. Green, R.M. Crawford, J.T. Hockmeyer, M.S. Meltzer, and C.A. Nacy Leishmania major amastigotes initiate the l-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha J. Immunol. 1990 4290 4297
7. C. Bogdan, H. Moll, W. Solbach, and M. Röllinghoff Tumor necrosis factor-alpha in combination with interferon-gamma, but not with interleukin 4 activates murine macrophages for elimination of Leishmania major amastigotes Eur. J. Immunol. 20 1990 1131 1135
8. F.Y. Liew, Y. Li, and S. Millott Tumor necrosis factor-α synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide J. Immunol. 145 1990 4306 4310
9. H. Himmelrich, P. Launois, I. Maillard, T. Biedermann, F. Tacchini-Cottier, R.M. Locksley, M. Rocken, and J.A. Louis In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease J. Immunol. 164 2000 4819 4825
10. P. Wilhelm, U. Ritter, S. Labbow, N. Donhauser, M. Röllinghoff, C. Bogdan, and H. Körner Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF J. Immunol. 166 2001 4012 4019
11. U. Ritter, J. Mattner, J.S. Rocha, C. Bogdan, and H. Körner The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain Microbes Infect. 6 2004 559 565
12. R. Chakour, R. Guler, M. Bugnon, C. Allenbach, I. Garcia, J. Mauel, J. Louis, and F. Tacchini-Cottier Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal Infect. Immun. 71 2003 5287 5295
13. F. Conceicao-Silva, M. Hahne, M. Schröter, J. Louis, and J. Tschopp The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity Eur. J. Immunol. 28 1998 237 245
14. F.-P. Huang, D. Xu, E.-O. Esfandiari, W. Sands, X. Wei, and F.Y. Liew Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production J. Immunol. 160 1998 4143 4147
15. H. Körner, M. Cook, D.S. Riminton, F.A. Lemckert, R. Hoek, B. Ledermann, F. Köntgen, B. Fazekas de St Groth, and J.D. Sedgwick Distinct roles for lymphotoxin-α and tumour necrosis factor in lymphoid tissue organogenesis and spatial organisation defined in gene targeted C57BL/6 Mice Eur. J. Immunol. 27 1997 2600 2609
16. P. Wilhelm, D.S. Riminton, U. Ritter, F.A. Lemckert, C. Scheidig, R. Hoek, J.D. Sedgwick, and H. Korner Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs Eur. J. Immunol. 32 2002 1993 2003
17. H. Körner, E. Cretney, P. Wilhelm, J.M. Kelly, M. Röllinghoff, J.D. Sedgwick, and M.J. Smyth Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype J. Exp. Med. 191 2000 89 96
18. W. Solbach, K. Forberg, E. Kammerer, C. Bogdan, and M. Röllinghoff Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice J. Immunol. 137 1986 702 711
19. S. Stenger, H. Thüring, M. Röllinghoff, and C. Bogdan Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major J. Exp. Med. 180 1994 783 793
20. U. Ritter, A. Meissner, C. Scheidig, and H. Körner CD8alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis Eur. J. Immunol. 34 2004 1542 1550
21. S. Stenger, N. Donhauser, H. Thüring, M. Röllinghoff, and C. Bogdan Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase J. Exp. Med. 183 1996 1501 1514
22. S.A. Miles, S.M. Conrad, R.G. Alves, S.M. Jeronimo, and D.M. Mosser A role for IgG immune complexes during infection with the intracellular pathogen Leishmania J. Exp. Med. 201 2005 747 754
23. T.R. Mosmann, H. Cherwinski, M.W. Bond, M.A. Giedlin, and R.L. Coffman Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins J. Immunol. 136 1986 2348 2357
24. F.D. Finkelman, I.M. Katona, T.R. Mosmann, and R.L. Coffman IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses J. Immunol. 140 1988 1022 1027
25. F.Y. Liew, C. Parkinson, S. Millott, A. Severn, and M. Carrier Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNFα mediates host protection against cutaneous leishmaniasis Immunol. 69 1990 570 573
26. R.G. Titus, B. Sherry, and A. Cerami Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis J. Exp. Med. 170 1989 2097 2104
27. C.M. Theodos, L. Povinelli, R. Molina, B. Sherry, and R.G. Titus Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo Infect. Immunol. 59 1991 2839 2842
28. S. de Kossodo, G.E. Grau, J.A. Louis, and I. Müller Tumor necrosis factor alpha (TNF-alpha) and TNF-beta and their receptors in experimental cutaneous leishmaniasis Infect. Immun. 62 1994 1414 1420
29. S.T. Kanaly, M. Nashleanas, B. Hondowicz, and P. Scott TNF receptor p55 is required for elimination of inflammatory cells following control of intracellular pathogens J. Immunol. 163 1999 3883 3889
30. L.Q. Vieira, M. Goldschmidt, M. Nashleanas, K. Pfeffer, T. Mak, and P. Scott Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication J. Immunol. 157 1996 827 835
31. M. Nashleanas, S. Kanaly, and P. Scott Control of Leishmania major infection in mice lacking TNF-receptors J. Immunol. 160 1998 5506 5513
32. G.F. Spath, L.F. Lye, H. Segawa, D.L. Sacks, S.J. Turco, and S.M. Beverley Persistence without pathology in phosphoglycan-deficient Leishmania major Science 301 2003 1241 1243
33. N. Noben-Trauth, W.E. Paul, and D.L. Sacks IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains J. Immunol. 162 1999 6132 6140